A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight loss in a real-world setting because patients discontinue treatment or use ...

A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...

Early-stage study results suggest that a single shot of the company’s therapy, which works differently than GLP-1 medicines, ...

Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

Eli Lilly is a global healthcare giant, generating strong growth from a diverse portfolio of blockbuster medications. Viking ...

Health experts are raising concerns for women using popular weight loss medications, particularly GLP-1s like Wegovy, ...